Loai M. Sa’adah
Mobile: (+971) 50 69 42 451
Email: loai_m_s@hotmail.com
Loai Mohammed Sa’adah
WORK EXPERIENCES:
1. Clinical Pharmacist (Senior & Team Supervisor), Hired through Global Medical
Solutions to work in Zayed Military Hospital, Abu Dhabi; March 2010 – Current.
Duties & Responsibilities: Dr. Sa’adah is currently serving as the clinical pharmacy
team supervisor at Zayed Military Hospital in addition to his specialized practice
of clinical pharmacy with a broad interest in pharmacotherapy and nutrition
support including that given to medical (e.g. cardiovascular), oncology, critical
care, pediatrics, and surgery patients. He reports directly to the Head of
Pharmacy and represent the department in a number of committees within and
outside the hospital including charts, infectious diseases, and local purchase
committees as well as pharmacy and therapeutics committee. He also led the
team who initiated and expanded the Intravenous admixtures as well as the unitdose services at the hospital. Dr. Sa’adah arranged a number of clinical pharmacy
seminars and contributed to the continuous education programs in the hospital.
In addition, he worked in teams and published on a number of research projects.
Moreover, he was part of the pharmacy and hospital teams who worked on
passing the Joint Commission for International Accreditation Survey in 2011 and
2014. He helped establish the first pharmacist-managed anticoagulation clinic in
the hospital. Furthermore, he organized the first Hospital Pharmacy Conference
in the Middle East Region in May 2014. He is both a national and international
invited speaker on various topics. Examples of quality improvement projects Dr.
Sa’adah initiated and played a major role in are:
 Medication Reconciliation for all patients on admission, transfer, and
discharge. (Best Practice according to JCIA in 2014).
 Evaluation of utilization of a number of medications such as meropenem,
dabigatran, liraglutide, and ticagrelor.
 Development of policies and guidelines, and optimizing prescribing for
vancomycin, warfarin, meropenem, controlled medications and total
parenteral nutrition.
2. Clinical Pharmacy Specialist (Pediatrics), Pediatric Pharmacotherapy Specialty
Group, Urban & Cure Pharmacy, Abu Dhabi, UAE; August 2008 – November 2009.
Duties & Responsibilities: Dr. Sa’adah initiated this idea and project during his
lecture titled “the role of the pediatric clinical pharmacy specialist” in the nationwide continuous professional education (CPE) program in Abu Dhabi, September
2008. Three parties were interested in supporting Dr. Sa’adah’s project. First,
Urban and Cure Pharmacy will fund the project and provide the locations for
1
Loai M. Sa’adah
Mobile: (+971) 50 69 42 451
Email: loai_m_s@hotmail.com
pediatric pharmacy practice. These locations will initially be pharmacy locations
that will be reengineered to facilitate the delivery of pediatric pharmacy services.
Second, Dimensions is a medical informatics company that will be responsible
for implementing the informatics aspects of the project such developing a
website for the group and providing pharmacy, insurance, and patient databases.
Last, the Health Authority of Abu Dhabi will provide the guidelines and approvals
for the practice. Dr. Sa’adah will lead the project and volunteer as an expert
consultant while recruiting new consultants.
3. Oncology & Clinical Pharmacy Specialist (Locum), Gulf International Cancer
Center in affiliation with the George Washington University Medical Center, Abu
Dhabi, UAE; October 2008 – January 2009.
Duties & Responsibilities: Dr. Sa’adah was recruited through Urban and Cure
Pharmacy as a locum pharmacist (3-month contract as Oncology Pharmacy
Specialist) based on the request of Gulf International Cancer Center in affiliation
with the George Washington University Medical Center. Dr. Sa’adah was the first
pharmacist in this center and served as the leader and founder of the
chemotherapy pharmacy services. Dr. Saadah used his strong relations and
communications skills to build the pharmacy stocks and the intravenous
chemotherapy clean room and practice per the standards of the Joint
Commission of International Accreditation (JCIA). Dr. Saadah worked on a team
of medical and radiation oncology consultants and oncology specialist nurses to
provide chemotherapy services to cancer patients and for the first time in a
private, specialized, day-case, cancer treatment center in the UAE.
4. Clinical Pharmacy/Pharmacotherapy Specialist (Pediatrics), Tawam Hospital &
Johns Hopkins Medicine, Al Ain, UAE; December 2007 – August 2008.
Duties & Responsibilities: Dr. Saadah Lead the pharmacists practicing in the
pediatric department and units. Dr. Saadah served as a national and
international speaker invited to conferences in USA, UK, UAE, and other
countries. Dr. Saadah Initiated and conducted the first UAE-wide Tawam
Pharmacotherapy Workshops which was evaluated by attendants as strongly
satisfactory (more than 4.5 out of 5) and helped double the passing rate in the
Board Exams for the year 2009 (20% to 40%). Dr. Saadah also continued to be
the primary clinical pharmacy practitioner in the areas of pediatric and neonatal
intensive care units and a primary investigator in a number of clinical research
projects, both nationally and internationally, utilizing artificial intelligence and in
various medical departments including infectious diseases, cardiology, critical
care, neurology, and pediatrics.
5. Clinical Pharmacist, Neonatal and Pediatric Intensive Care Units, Tawam Hospital
& Johns Hopkins Medicine, Al Ain, UAE; April 2007 – August 2008.
Duties & Responsibilities: Dr. Saadah rounded with medical and interdisciplinary
teams in the pediatric and neonatal units. He served as the clinical pharmacist in
2
Loai M. Sa’adah
Mobile: (+971) 50 69 42 451
Email: loai_m_s@hotmail.com
pediatrics and neonatal intensive care unit providing pharmacy consultations,
education, and research. He was the first pharmacy prescriber in this area. An
example project from this post is the evaluation of the use of palivizumab during
a nosocomial outbreak of respiratory syncytial virus (RSV).
6. Clinical Pharmacist(Maternity & Pediatrics), Department of Pharmaceutical
Services, Al Wasl Pediatrics and Maternity Hospital (currently known as Latifa
Hospital), Department of Health and Medical Services (DOHMS), Dubai, UAE;
August, 2005 – February 2007.
Duties & Responsibilities: Dr. Saadah rounded with medical teams in the
pediatric, neonatal, obstetric, and gynecologic units. Dr. Saadah established for
the first time prescribing privileges for pharmacists and automated, pharmacycentralized, intravenous admixtures and parenteral nutrition services. He served
as a supervisor for colleagues in various areas of practice including controlled
medications, thalassemia, and in-patient as well as out-patient services. He was
consulted occasionally on patients in other hospitals and departments within the
Department of Health and Medical Services.
7. Pharmacist In-charge, Al Shams Pharmacy, Sharjah, UAE, December 2004 – July
2005.
Duties & Responsibilities: Dr. Saadah supervised the pharmacy and provided
clinical consultations and disease management and follow-up services in various
areas of practice including blood pressure, cholesterol, diabetes, smoking
cessation, and first aid
8. Scholar, College of Pharmacy, Jordan University of Science and Technology
(JUST), Jordan; January, 2001 – November, 2004.
Duties & Responsibilities: As a distinguished student Dr. Saadah was awarded a
scholarship as a faculty member of Pharmacy.
9. Research Assistant, Infectious Diseases Laboratory, College of Pharmacy (COP) The University of Iowa (UI), USA; June, 2001 – December 2002.
Duties & Responsibilities: Dr. Saadah managed the infectious diseases supplies
and projects, and assist in the in-vitro, in-vivo, as well as clinical research in the
infectious diseases area of pharmacy practice.
10. Medical Representative, Hikma Pharmaceuticals, Jordan; May, 1999 September, 2000
Duties & Responsibilities: Dr. Saadah served a specialized hospital representative
who has been given quarterly budgets to spend on scientific meetings, activities,
and presentations, made field-visits, and marketed injectable medications and
products for surgical use. Dr. Saadah was promoted in the first few year of work
due to his accomplishments.
QUALIFICATIONS:
1. Board Certified Nutrition Support Pharmacist (BCNSP), Board of Pharmaceutical
Specialties, USA, 2008.
3
Loai M. Sa’adah
Mobile: (+971) 50 69 42 451
Email: loai_m_s@hotmail.com
2. Advanced Cardiovascular Life Support (ACLS), American Heart Association, USA,
2008.
3. Board Certified Pharmacotherapy Specialist (BCPS), Board of Pharmaceutical
Specialties, USA, 2007.
4. Doctor of Pharmacy (PharmD.), Special Honors and High Distinction, UI, Iowa City,
Iowa, USA, 2006.
5. Master of Science (MSc) in Hospital Clinical Pharmacy, UI, Iowa City, Iowa, USA,
2002.
6. Bachelor of Science (BSc) in Pharmacy, Jordan University of Science & Technology
(JUST), Irbid, Jordan, 1999.
LEADERSHIP EXPERIENCES:
1. Organized the 1st Hospital Pharmacy Conference in Abu Dhabi, UAE, 2014.
2. Implement pharmacist-managed anticoagulation clinic at Zayed Military Hospital,
Abu Dhabi, UAE, 2014.
3. Lead and Helped in implementing intravenous admixtures and unit dose services
at Zayed Military Hospital, Abu Dhabi, UAE, 2012.
4. Lead and established together with Nursing and Medical Colleagues the first
specialized chemotherapy services at a private, day-case, cancer-treatment
medical center in the United Arab Emirates (UAE), Gulf International Cancer
Center (GICC), Al Bahiya City, Abu Dhabi, UAE, October 2008.
5. Initiate the idea and lead the project of establishing a nation-wide pediatric
pharmacotherapy specialty group in the United Arab Emirates, August 2008.
6. Initiated and lead the pharmacotherapy preparatory workshops at Tawam
Hospital in affiliation with Johns Hopkins Medicine which helped improve the
pass rate of colleagues in the board exams for the year 2008, May through
September 2008.
7. Established pharmacy-centralized, fully automated, intravenous admixtures and
parenteral nutrition service (mostly neonatal intensive care unit patients) in Al
Wasl Hospital, Dubai, United Arab Emirates, March 21, 2006.
8. Performed complex pharmacotherapy outcomes evaluations as opposed to the
usual medication utilization reviews on injectable antibiotics in Al Wasl Hospital,
since August 2006.
9. Pioneering in the application of artificial neural networks and artificial
intelligence modeling in clinical pharmacy research.
10. Developed policies, procedures and protocols related to pharmacy practice, and
collaboration agreements with medical, and other professionals in Al Wasl
Hospital, Dubai, United Arab Emirates.
CLERKSHIPS/CLINICAL ROTATIONS:
1. Drug Inforamtics/Information and Research March 2006 – July 2006.
4
Loai M. Sa’adah
Mobile: (+971) 50 69 42 451
Email: loai_m_s@hotmail.com
2. Acute Care Medicine, Family Practice, Infectious Diseases, Pediatrics, Neurology,
University of Iowa Hospitals and Clinics (UIHC), May 2003 through April 2004.
3. Community Pharmacy, OSCO DRUGS, January 2004, Old Capitol, Iowa city, IA, USA
4. Community Pharmaceutical Care – Osterhaus Pharmacy, December 2003, Maquoketa,
IA, USA
PROFESSIONAL MEMBERSHIPS:
1. Membership of the Cardiology Practice and Research Network, American College
of Clinical Pharmacy, 2013 – Current.
2. Membership of the Critical Care Practice and Research Network, American
College of Clinical Pharmacy, 2013 – Current.
3. Membership of the Pediatric Practice and Research Network, American College
of Clinical Pharmacy, 2007 – Current.
4. Membership of the Hematology & Oncology Practice and Research Network,
American College of Clinical Pharmacy. (Historical)
5. Membership of the Infectious Diseases Practice and Research Network,
American College of Clinical Pharmacy, (Historical)
6. Membership of the American College of Clinical Pharmacy (ACCP), 2006 –
Current.
7. Membership of the American Society of Health System Pharmacists (ASHP), 2003
- Current.
8. Membership of the American Academy of Pharmaceutical Sciences (AAPS), 2002
- 2003.
9. Membership of the Jordan Pharmacists Association (JPA), 1999 - Current.
HONORS AND AWARDS:
1. Appreciation Certificate from Medical Services Corps for commitment for the
educational activities within Continuing Medical Education, Undergraduate &
Postgraduate programs at Zayed Military Hospital, May 2012.
2. Best speaker certificate and award for speaking in the continuous education program
for the emirate of Abu Dhabi, July 2008.
3. Award for speaking at the first national clinical pharmacy day in the continuous
education program for the emirate of Abu Dhabi, September 20th 2008.
4. Recognition and appreciation by Tawam Hospital in affiliation with Johns Hopkins
Medicine for passing the Board Exams in 2007 and setting the standards for colleagues
at Tawam Hospital, April 2008.
5. Finalist in the ACCP research forum, Memphis, Tennessee, April 21-24th 2007. Study title:
“Complications following elective and non-elective cesarean section: a neural network
analysis approach and prediction of post-surgical febrile morbidity and infections. Loai
M. Saadah, Ronald A. Herman, Samer S. Saadah
6. Special Honors and High Distinction, PharmD, UI, JUL. 2006.
5
Loai M. Sa’adah
Mobile: (+971) 50 69 42 451
Email: loai_m_s@hotmail.com
7. Scholarship for the PharmD. and MSc in Hospital Clinical Pharmacy from JUST, JAN. 2001
– NOV. 2004.
8. Dean’s list, College of Pharmacy – UI, OCT. 2003.
9. First on class, first year Pharmacy, JUST, 1994/95.
10. First on class all through elementary and secondary school.
PUBLICATIONS:
1. Saadah M, El Beshari M, Saadah LM, Hamdallah H, Alloub Z, Al Zaabi A, BenMussa A, Ben-Nour A. Progressive Myoclinic Epilepsy Type I. Report of an Emirati
Family and Literature Review. Epilepsy and Behavior Case Reports. 2014; 2:112117.
2. Saadah LM, Nazzal YM, Abdelmaksoud SI, Nazzal MK, Abu Sabiha EL, Al Qasemi
AR. Predictors of Physicians Acceptance of Clinical Pharmacy Recommendations
at a Military Hospital in the United Arab Emirates. (In Process).
3. Saadah LM, Chedid F, Sohail R, Nazzal Y, Al Kaabi M, Rahmani A. Palivizumab
Prophylaxis during nosocomial outbreaks of respiratory syncytial virus in a
neonatal intensive care unit. Predicting Effectiveness with an artificial neural
network model. Pharmacotherapy. 2013 Jul 29. doi:10.1002/phar.1333. [Epub
ahead of print]
4. Nazzal ME, Saadah MA, Saadah LM, Al Omari MA, Al Oudat ZA, Nazzal MS, El
Beshari MY, Al Zaabi AA, Al Nuaimi YI. Management options of chronic low back
pain: a randomized blinded clinical trial. Neurosciences (Riyadh). 2013
Apr;18(2):152-9.
5. Saadah LM, Sohail MR, Uslan DZ, Friedman PA, Hayes DL, Wilson WR,
Steckelberg JM, Baddour LM. Predicting cardiac device-related infective
endocarditis: artificial neural networks versus diagnostic transesophgeal
echocardiography. (In process)
6. Rajar A, Saadah M, Saadah L. Clinical Semiology and Artificial Neural Networks:
predicting computed tomography imaging results in localization-related epilepsy
syndromes. (In process)
7. Saadah LM, Herman RA. Cefuroxime with or without metronidazole versus
piperacillin and tazobactam in antimicrobial surgical prophylaxis in elective and
non-elective cesarean section: a neural network analysis approach. (In Process)
8. Saadah LM, Herman RA. Cefuroxime with or without metronidazole versus
piperacillin and tazobactam in antimicrobial surgical prophylaxis in elective and
non-elective cesarean section: from drug utilization reviews to pharmacotherapy
outcomes evaluation. (In process).
9. Saadah LM, Herman RA. Towards full integration of pharmacy electronic systems:
the development of an enterprise software solution for intravenous admixtures
and parenteral nutrition. (In process)
10. Saadah LM, Ernst EJ. ABT-773 pharmacodynamics in neutropenic murine model
for pneumococcal lung infections: different levels versus different types of
antimicrobial kill activity. (In process)
6
Loai M. Sa’adah
Mobile: (+971) 50 69 42 451
Email: loai_m_s@hotmail.com
11. Saadah MA, Saadah LM. Psychiatric Presentations of Neurobrucellosis. (In
preparation).
12. Nazzal ME, Saadah MA, Saadah LM, and Trebinjac SM. Acute ischemic stroke:
Relationship of brain lesion location & functional outcome. Disability and
Rehabiliation 2009, 31(18): 1501-1506.
13. Saadah MA,Thankre M, Saadah LM and Nazzal ME. Homocysteinemia and Stroke in
Vegetarians. Neurosciences 2006, 11(2):107-111.
14. Saadah MA, Al Shunnar Q, Saadah LM, Shogan A, Afifi H and Inshasi J. Atypical
Presentations of conus medullaris and filum terminale ependymoma:A report of three
cases and literature review. Clinical Neuroscience Journal, 2004, 11:3, 268-272.
15. Saadah MA and Saadah LM. Autonomy and Rehabilitation: A critical Review of
Literature. Neurosciences, 2004, 9:2, 84-90.
16. Saadah MA and Saadah LM. Attention Deficit Hyperactivity Disorder:Future Perspectives.
International J Ther and Rehabil, 2004, 11(8):381-388.
17. Hoffman HL, Klepser ME, Ernst EJ, Petzold CR, Saadah LM, Doern GV. Influence of
Macrolide Susceptibility on Efficacies of Clarithromycin and Azithromycin against
Streptococcus pneumoniae in a Murine Lung Infection Model. Antimicrobial Agents and
Chemotherapy 2003; 47:739-46.
18. Sa'adah, Loai Mohammed. The Pharmacodynamics of ABT-773, a new ketolide
antibiotic, in a neutropenic murine model of pneumococcal lung infection. 2002. Thesis
(MS)—Pharmacy—The University of Iowa.
19. Saadah MA, Shawabkeh A, Saadah LM and Inshasi J. Pilomotor Seizures: Symptomatic
Versus Idiopathic, Report of two cases and Literature review. Seizure-European J of
Epilepsy, 2002, 11:7,455-459.
PRESENTATIONS:
1. Saadah LM, Rational Prescribing for Family Practice Residents. Medical
Education Center. Zayed Military Hospital September 8th 2014. Abu Dhabi, UAE.
(Invited Speaker)
2. Saadah LM. Pharmacists as Principal Investigators in Hospitals. 1st Hospital
Pharmacy Conference, May 23rd 2014, Abu Dhabi, UAE. (Invited Speaker)
3. Saadah LM. Combining Artificial Intelligence and Antibodies in Clinical Research
and Practice. 6th Annual International Congress of Antibodies. April 25 – 28 2014.
Dalian, China. (Invited)
4. Nazzal ME, Saadah MA, Saadah LM, Al Omari MA, Al Oudat ZA, Nazzal MS.
Management Options of Chronic Low Back Pain: A Randomized Blinded Trial.
Oral Presentation Number O-116. 10th Mediterranean Congres of Physical
Therapy and Rehabilitation Medicine & 13th National Congress of the Serbian
Association of Physical Medicine & Rehabilitation (SAPMR), Budva, Montenegro,
September 29th to October 2nd 2013.
5. Saadah LM. Update on Respiratory Infections. 3rd National Clinical Pharmacy
Conference. September 13th 2013. Abu Dhabi, UAE.
7
Loai M. Sa’adah
Mobile: (+971) 50 69 42 451
Email: loai_m_s@hotmail.com
6. Several Presentations at Zayed Military Hospital and Family Medicine Clinic in
the Pharmacy and Pediatrics Departments, as well as hospital-wide clinical
pharmacy seminars in the Continuous Medical Education program at Zayed
Military Hospital. Since March 2010 till now.
7. Sohail MR, Saadah LM, Uslan DZ, et al. Using artificial neural networks cardiac
rhythm management device-related infective endocarditis. Interscience
Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September
2009, San Francisco, CA, USA.
8. Saadah LM. Role of the Pediatric Clinical Pharmacy Specialist, 1st National Clinical
Pharmacy Day, Continuous Professional Education Program, Al Raha Beach Hotel,
September 2008, Abu Dhabi, UAE. (Invited Speaker)
9. Saadah LM. Artificial neural networks in Pharmacy and Medicine. Europe
Palisade User Conference 2008, April, 2008, London, UK. (Invited speaker)
10. Saadah LM. Cardiac device-related infective endocarditis: Evaluation of
Predictors. Intensive Care Unit Continuous Education Program, Tawam Hospital,
February 2008, Al Ain, UAE. (Invited Speaker)
11. Saadah LM. Pharmacotherapy Evaluations: Borrowing into Spiral CT scan for
flank pain in the emergency department. Emergency Department Continuous
Education Program, Tawam Hospital, January 2008, Al Ain, UAE. (Invited speaker)
12. Saadah LM. Applications of artificial neural networks in Neonatology. Al Ain
Pediatrics Club, March 2008, Al Ain, UAE.
13. Saadah LM, Herman RA. Complications following elective and non-elective
cesarean section: a neural network analysis and prediction of post-operative
febrile morbidity and infections. (Accepted & Finalist) for ACCP Research forum,
April 2006, Memphis, Tennessee, USA).
14. Stephanie A. Knechtel, Michael E. Klepser, Erika J. Ernst, Doug Keele, Ellen Roling,
Loai Sa’adah, Gary V. Doern. Relationship Between Clarithromycin Minimum
Inhibitory Concentration and Survival in a Pneumococcal Murine Lung Infection
Model. (Submitted Poster for American College of Clinical Pharmacy Research
forum, April 2006, Memphis, Tennessee, USA).
15. Saadah LM, Herman RA. Cefuroxime with or without metronidazole versus
piperacillin and tazobactam in antimicrobial surgical prophylaxis in elective and
non-elective cesarean section: from drug utilization reviews to pharmacotherapy
outcomes evaluation. Presented at 41st ASHP midyear clinical meeting,
December 2006, Anaheim, California, USA.
16. Saadah LM. Artificial Neural Networks: Basic Introduction and Perspectives in
Clinical Neurology, 40th Emirates Neurology Society (EMINS) Meeting, November
2006, Dubai, United Arab Emirates. (Invited Speaker)
17. Saadah MA, Saadah LM. Neurobrucellosis at Rise of Present Millennium. American
Academy of Neurology, 58th Annual Meeting, Abstract No. 1576, 2006, San Diego,
California, USA.
8
Loai M. Sa’adah
Mobile: (+971) 50 69 42 451
Email: loai_m_s@hotmail.com
18. Azba A, Sa’adah L, Sobhi A, Siddiqui H. Neural Networks: A true power of reason.
Presented at Dubai Pharmacy & Technology (DUPHAT) Meeting, 2006, Dubai, UAE.
19. Sa’adah L, Dina Dillon. Cryptosporidiosis in Patients with Human Immunodeficiency
Virus (HIV). Interns Meeting, Pharmaceutical Care Department, UIHC, 2003, Iowa city,
Iowa, USA.
20. Sa’adah L, Roy Davis. Hyperhomocystinemia. Interns Meeting, Pharmaceutical Care
Department, University of Iowa Hospitals & Clinics (UIHC), 2003, Iowa city, Iowa, USA.
21. Sa’adah L, Ernst E, Klepser M, Doern G. The pharmacokinetics and Pharmacodynamics of
ABT-773, a new ketolide antibiotic, in mice. Abstract no. W5355, AAPS meeting, 2002,
Toronto, Canada.
22. Sa’adah L, Ernst E. ABT-773. Clinical Pharmacy Seminar – COP, UI, 2002, Iowa, USA.
23. Sa’adah L, Ernst E. Pneumococcal Resistance to the Macrolides. Clinical Implications.
Clinical Pharmacy Seminar – COP, UI, 2001, Iowa, USA.
24. Sa’adah L. Injectable Antibiotics, Anaesthesia Medications, Pain Medications, (Multiple
Presentations in Group Meetings). Hikma Pharmaceuticals, 1999-2000 Jordan.
CONFERENCES:
1. Several Conferences on Medication Safety, Cold Chain Supply, Military Medicine,
Various areas of Medicine, and Clinical Pharmacy. UAE, March 2010 till now.
2. Multiple Sclerosis Preceptorship, Munich, Germany, March 2012.
3. Lebanon Neurology Society Meeting, Broumana, Lebanon, September 2011.
4. DUPHAT, Dubai, UAE, March 2011.
5. Emirates Neonatal Society Meeting, Al Ain, March 2009. (Invited Speaker)
6. Symposium in Evidence-Based Neonatal Guidelines, September 2007, Sharjah UAE.
7. First Al Ain Pediatrics International Conference, May 2007, Al Ain, UAE.
8. American Society of Health System Pharmacy Midyear Clinical Meeting, December 2006,
Anaheim, California, USA.
9. American College of Clinical Pharmacy Meeting, October 2006, Saint Louis, Missouri,
USA.
10. Dubai Pharmacy and Technology Meeting, March 2006, Dubai, UAE.
11. Emirates Neurology Society International Meeting and 5th GCC Symposium, March 2006,
Dubai, UAE.
12. Pan Arab Union of Neurological Sciences Meeting, March 2005, Jeddah, KSA.
13. ASHP Midyear, December 2003, New Orleans, Louisiana, USA.
14. American Association of Pharmaceutical Sciences (AAPS), November 2002, Toronto,
Canada.
PRESS RELEASES:
1. Artificial Intelligence Helps Diagnose Cardiac Infections. Mayo Clinic. Sep. 14th 2009.
Access through http://www.disabled-world.com/news/research/artificial-
intelligence.php
INTERESTS:
9
Loai M. Sa’adah
Mobile: (+971) 50 69 42 451
Email: loai_m_s@hotmail.com
1. Pharmaceutical care development and practice in both the hospital and community
settings.
2. Provision of pharmaceutical care within the pharmacotherapy domain of practice.
3. Special interest in Infectious, Neurological, Cardiovascular, Nutritional and Pediatrics
Diseases Clinical Pharmacy.
4. Applying artificial intelligence, genomics, and national and international pharmacy
networking in pharmacy and medicine.
5. Medication Informatics/Information
LANGUAGES SPOKEN:
1.
2.
3.
4.
English (most used)
Arabic (native language)
French (2nd out of 12 levels)
Urdu (few lay medical and pharmaceutical terms)
HOBBIES:
Swimming, Traveling, Reciting, Reading, Strategy and Tactic games.
Personal Details:
DATE OF BIRTH:
October 1st 1976
PLACE OF BIRTH: Kuwait
NATIONALITY:
10
Jordanian
Loai M. Sa’adah
Mobile: (+971) 50 69 42 451
Email: loai_m_s@hotmail.com
MARITAL STATUS: Married
CURRENT CORRESPONDANCE ADDRESS:
P.O. Box 3740
Dr. Loai M Saadah – Pharmacy Department
Zayed Military Hospital
Tel: (Home) 00971 2 55 36 241
(Work) 00971 2 40 52 028
00971 2 40 55 950
(Mobile) 00971 50 69 42 451
PERMANENT ADDRESS:
Abu Abdullah Al Qudai St. # 7.
Tareq 11947
Amman – Jordan
Tel: 00962 6 50 59 447
REFERENCES:
Available upon request
11